| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020527428 |
| P356 | DOI | 10.1007/S10549-011-1371-Z |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10549-011-1371-z |
| P698 | PubMed publication ID | 21298476 |
| P5875 | ResearchGate publication ID | 49814740 |
| P50 | author | Ian Ellis | Q55300055 |
| P2093 | author name string | A R Green | |
| K S Zänker | |||
| D G Powe | |||
| F Entschladen | |||
| M J Voss | |||
| H O Habashy | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 457-463 | |
| P577 | publication date | 2011-02-06 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study | |
| P478 | volume | 130 |
| Q35829723 | A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer |
| Q35077524 | A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response |
| Q35949297 | Beta-adrenergic blocking drugs in breast cancer: a perspective review |
| Q37654991 | Biomarker identification in breast cancer: Beta-adrenergic receptor signaling and pathways to therapeutic response |
| Q47566245 | Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management |
| Q47372688 | Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database |
| Q34654398 | Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines |
| Q37613495 | Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model |
| Q47977198 | Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. |
| Q60922325 | Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response |
| Q41585931 | Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives |
| Q33555154 | Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches |
| Q35803280 | Molecular pathways: beta-adrenergic signaling in cancer |
| Q38871033 | Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer. |
| Q55192373 | Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. |
| Q36043833 | Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients |
| Q37448247 | Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer |
| Q37465305 | Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts |
| Q39177632 | Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. |
| Q38892059 | Stress, catecholaminergic system and cancer |
| Q84639335 | Targeted therapies: Using β-blockers to inhibit breast cancer progression |
| Q34652972 | Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma |
| Q26740401 | The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers |
| Q37389659 | The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure |
| Q92890186 | The prognostic value of ADRA1 subfamily genes in gastric carcinoma |
| Q38246692 | The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action |
| Q36570909 | The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. |
| Q37701617 | Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer |
| Q36561384 | Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients |
| Q36213505 | β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells |
| Q89879738 | β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3 |
| Q36321486 | β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. |
Search more.